Rita Johnson-Greene is recorded as CFO at Ocugen, Inc. (OCGN) since February 9, 2026. The newest filing on record that lists Rita Johnson-Greene as CFO at Ocugen, Inc. (OCGN) is dated April 28, 2026. Ocugen, Inc. reported in an 8-K filed February 9, 2026 that Rita Johnson-Greene was appointed principal financial officer. Ocugen, Inc. reported in an 8-K filed February 9, 2026 that Rita Johnson-Greene was appointed Chief Financial Officer, effective February 9, 2026. Rita Johnson-Greene has spoken on 3 earnings calls across 1 company, most recently for Ocugen, Inc. on November 4, 2026. Ocugen, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ocugen, Inc. includes Shankar Musunuri (CEO), Quan Anh Vu (CFO), Ramesh Ramachandran (CFO and Chief Accounting Officer) and 5 others.
“The Board of Directors of the Company appointed Ms. Johnson-Greene to serve as the Company’s principal financial officer, effective immediately following the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Effective Time”).”
Ocugen, Inc. Form 8-K, filed February 9, 2026
· Read the filing
“On February 9, 2026, Ocugen, Inc. (the “Company”) announced the appointment of Rita Johnson-Greene as the Company’s Chief Financial Officer, effective February 9, 2026.”
Ocugen, Inc. Form 8-K, filed February 9, 2026
· Read the filing
Rita Johnson-Greene on recent calls
“Our cash, cash equivalents, restricted cash, and short-term investments totaled $84.6 million as of September 30, 2026. We expect this balance to support our cash runway into 2028, which funds two of our three late-stage programs through their anticipated BLA filings.”
“Total operating expenses for the three months ended June 30th, 2026 for $17.9 million and included research and development expenses of $10.7 million and general and administrative expenses of $7.2 million.”
“Total operating expenses for the three months ended March 31, 2026 were $19.4 million and that included research and development expenses of $11.3 million and general and administrative expenses of $8.1 million, compared to total operating expenses for the three months ended March 31, 2025 of $16 million that included…”
